Physician profile

Liandra Jung

Optometrist · Berkeley, CA

NPI 1386252849

$14,790.07

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

See the full distribution for Optometrist

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$3,228.95
Food and Beverage$627.35

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Coopervision INC. $12,126.63 2020-2024 Misight Contact Lens, Paragon Crt, Ortho-K Contact Lens
Topcon Healthcare, INC. $1,547.39 2022
Valley Contax, INC. $911.85 2021
Johnson & Johnson Vision Care, INC. $111.42 2022
Dompe US, INC. $67.78 2023 Oxervate
Bausch & Lomb, A Division of Bausch Health US, LLC $25.00 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Liandra Jung

$14,790.07

in general payments reported 2019-2025

Years
2020-2024
Top company
Coopervision INC.

https://glasscript.com/doctor/7778066/liandra-jung

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.